Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DTP-Haemophilus influenza B-vaccine - Wockhardt

Next Previous
Search
Drug Profile

DTP-Haemophilus influenza B-vaccine - Wockhardt

Alternative Names: Diphtheria, acellular Pertussis, Tetanus and Hemophilus influenza b - Wockhardt; DTaP-Hib combination vaccine - Wockhardt

Latest Information Update: 23 Feb 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wockhardt
  • Class Bacterial vaccines; Haemophilus vaccines; Polysaccharides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Diphtheria; Haemophilus infections; Pertussis; Tetanus

Most Recent Events

  • 23 Feb 2022 No development reported - Phase-II/III for Diphtheria (In infants, Prevention) in India (IM) (CTRI2017-12-010803)
  • 23 Feb 2022 No development reported - Phase-II/III for Haemophilus infections (In infants, Prevention) in India (IM) (CTRI2017-12-010803)
  • 23 Feb 2022 No development reported - Phase-II/III for Pertussis (In infants, Prevention) in India (IM) (CTRI2017-12-010803)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top